Is a complete DSGN research report available?

No complete published report is available for Design Therapeutics, Inc. (DSGN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Design Therapeutics, Inc. (DSGN)

NASDAQ: DSGN · USD

$11.1

+0.44 (+4.1%)· Recorded snapshot

Market cap	692.8M
Net income (ttm)	-70.8M
EPS (ttm)	-$1.18
Shares out	62.6M
Volume	418,142
Beta	1.69

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -70.8M
EPS (ttm): -$1.18
Market cap: 692.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Metric	Value
Amount currency	USD
CIK code	0001807120
Company name	Design Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	25056L103
Earnings date	2026-11-09
Earnings time	amc
Employees	55
Employees change	-2
Employees growth	-3.51%
Enterprise value	$488M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2021-03-26
Is primary listing	Yes
Is SPAC	No
ISIN number	US25056L1035
Last 10-K release date	2026-03-09
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$692.8M
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$11.07
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	DSGN
U.S. state	California
Website	https://www.designtx.com

Metric

Value

Amount currency

USD

CIK code

0001807120

Company name

Design Therapeutics, Inc.

Country

United States

Country code

CUSIP number

25056L103

Earnings date

2026-11-09

Earnings time

amc

Employees

Employees change

-2

Employees growth

-3.51%

Enterprise value

$488M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2017

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2021-03-26

Is primary listing

Yes

Is SPAC

ISIN number

US25056L1035

Last 10-K release date

2026-03-09

Last earnings date

2026-08-03

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$692.8M

Market cap category

Small-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$11.07

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

DSGN

U.S. state

California

Website

https://www.designtx.com

Metric	Value
Earnings yield	-10.67%
FCF / EV yield	-11.53%
FCF yield	-8.08%
P/B ratio	3.3x
Price / tangible book value	3.38x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-10.67%

FCF / EV yield

-11.53%

FCF yield

-8.08%

P/B ratio

3.3x

Price / tangible book value

3.38x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-1.3M
ROA	-22.53%
ROA (5Y)	-14.52%
ROCE	-38.73%
ROE	-34.13%
ROE (5Y)	-21.36%
ROIC	-23.53%

Metric

Value

Profit per employee

$-1.3M

ROA

-22.53%

ROA (5Y)

-14.52%

ROCE

-38.73%

ROE

-34.13%

ROE (5Y)

-21.36%

ROIC

-23.53%

Metric	Value
EPS growth quarters	2
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-55,000
Depreciation and amortization	$619,000
EBIT	$-79M
EBITDA	$-78.3M
EPS	$-1.18
FCF per share	$-0.88
Financing cash flow	$45.9M
Free cash flow	$-55.1M
Free cash flow minus SBC	$-70M
Gross profit	$-58.8M
Investing cash flow	$2.4M
Net cash flow	$-6.8M
Net income	$-70.8M
Operating cash flow minus SBC	$-69.9M
Operating income	$-79M
Stock-based compensation	$14.8M

Metric

Value

Capital expenditures

$-55,000

Depreciation and amortization

$619,000

EBIT

$-79M

EBITDA

$-78.3M

EPS

$-1.18

FCF per share

$-0.88

Financing cash flow

$45.9M

Free cash flow

$-55.1M

Free cash flow minus SBC

$-70M

Gross profit

$-58.8M

Investing cash flow

$2.4M

Net cash flow

$-6.8M

Net income

$-70.8M

Operating cash flow minus SBC

$-69.9M

Operating income

$-79M

Stock-based compensation

$14.8M

Metric	Value
Book value per share	$3.23
Debt / equity	0.01
Long-term assets	$3.1M
Long-term liabilities	$2M
Net cash (debt)	$204.7M
Net cash / market cap	29.99%
Net cash growth	-4.48%
Net debt / equity	-1.01
Piotroski F-Score	1
Property, plant and equipment	$3.1M
Shareholders' equity	$201.9M
Tangible book value	$201.9M
Tangible book value per share	$3.23
Total assets	$215.1M
Total cash	$207.4M
Total debt	$2.7M
Total liabilities	$13.3M
WACC	13.47%

Metric

Value

Book value per share

$3.23

Debt / equity

0.01

Long-term assets

$3.1M

Long-term liabilities

$2M

Net cash (debt)

$204.7M

Net cash / market cap

29.99%

Net cash growth

-4.48%

Net debt / equity

-1.01

Piotroski F-Score

Property, plant and equipment

$3.1M

Shareholders' equity

$201.9M

Tangible book value

$201.9M

Tangible book value per share

$3.23

Total assets

$215.1M

Total cash

$207.4M

Total debt

$2.7M

Total liabilities

$13.3M

WACC

13.47%

Metric	Value
Current assets	$212M
Current liabilities	$11.2M
Current ratio	18.86
Net working capital	$-6M
Quick ratio	18.61
Working capital	$200.8M

Metric

Value

Current assets

$212M

Current liabilities

$11.2M

Current ratio

18.86

Net working capital

$-6M

Quick ratio

18.61

Working capital

$200.8M

Metric	Value
Buyback yield / dilution	-5.61%
Dividend yield	0%
Shareholder yield	-5.61%

Metric

Value

Buyback yield / dilution

-5.61%

Dividend yield

Shareholder yield

-5.61%

Metric	Value
150-day SMA	$12.80
1D price change	4.14%
1M price change	-8.66%
1M total return	-8.66%
1W price change	3.17%
1W total return	3.17%
1Y price change	58.82%
1Y return CAGR	58.87%
1Y total return	58.82%
20-day SMA	$11.01
200-day SMA	$12.15
3M price change	-6.82%
3M total return	-6.82%
3Y price change	448.02%
3Y return CAGR	76.28%
3Y total return	448.02%
50-day SMA	$12.85
50-day SMA vs 200-day SMA	50over200
52-week high	$17.25
52-week high date	2026-04-29
52-week low	$6.16
52-week low date	2025-11-04
5Y price change	-28.44%
5Y return CAGR	-6.48%
5Y total return	-28.44%
6M price change	-13.58%
6M total return	-13.58%
All-time high	$50.50
All-time high date	2021-03-26
All-time low	$1.94
All-time low date	2023-08-22
Average true range (ATR)	$0.65
Average volume	496.1K
Beta (1Y)	1.48
Beta (2Y)	1.1
Beta (5Y)	1.69
Change from 52-week high	-35.83%
Change from 52-week low	79.71%
Change from all-time high	-78.08%
Change from all-time low	470.62%
Change from open	6.03%
Day's gap	-1.79%
Dollar volume	$4.6M
High price	$11.07
Low price	$10.44
Monthly RSI	53.43
Open price	$10.44
Position in 52-week range	100%
Premarket change	1.79%
Premarket close	$10.63
Premarket price	$10.82
Previous close	$10.63
Price vs 150-day SMA	-13.52%
Price vs 20-day SMA	0.52%
Price vs 200-day SMA	-8.92%
Price vs 50-day SMA	-13.85%
Relative volume	0.85
Return from IPO open	-61.04%
Return from IPO price	-45.45%
RSI	46.36
Sharpe ratio	0.96
Sharpe ratio (3Y)	1.03
Sharpe ratio (5Y)	0.38
Sortino ratio	1.51
Sortino ratio (3Y)	1.7
Sortino ratio (5Y)	0.59
Volume	418.1K
Weekly RSI	45.06
YTD price change	18.02%
YTD total return	18.02%

Metric

Value

150-day SMA

$12.80

1D price change

4.14%

1M price change

-8.66%

1M total return

-8.66%

1W price change

3.17%

1W total return

3.17%

1Y price change

58.82%

1Y return CAGR

58.87%

1Y total return

58.82%

20-day SMA

$11.01

200-day SMA

$12.15

3M price change

-6.82%

3M total return

-6.82%

3Y price change

448.02%

3Y return CAGR

76.28%

3Y total return

448.02%

50-day SMA

$12.85

50-day SMA vs 200-day SMA

50over200

52-week high

$17.25

52-week high date

2026-04-29

52-week low

$6.16

52-week low date

2025-11-04

5Y price change

-28.44%

5Y return CAGR

-6.48%

5Y total return

-28.44%

6M price change

-13.58%

6M total return

-13.58%

All-time high

$50.50

All-time high date

2021-03-26

All-time low

$1.94

All-time low date

2023-08-22

Average true range (ATR)

$0.65

Average volume

496.1K

Beta (1Y)

1.48

Beta (2Y)

1.1

Beta (5Y)

1.69

Change from 52-week high

-35.83%

Change from 52-week low

79.71%

Change from all-time high

-78.08%

Change from all-time low

470.62%

Change from open

6.03%

Day's gap

-1.79%

Dollar volume

$4.6M

High price

$11.07

Low price

$10.44

Monthly RSI

53.43

Open price

$10.44

Position in 52-week range

100%

Premarket change

1.79%

Premarket close

$10.63

Premarket price

$10.82

Previous close

$10.63

Price vs 150-day SMA

-13.52%

Price vs 20-day SMA

0.52%

Price vs 200-day SMA

-8.92%

Price vs 50-day SMA

-13.85%

Relative volume

0.85

Return from IPO open

-61.04%

Return from IPO price

-45.45%

RSI

46.36

Sharpe ratio

0.96

Sharpe ratio (3Y)

1.03

Sharpe ratio (5Y)

0.38

Sortino ratio

1.51

Sortino ratio (3Y)

1.7

Sortino ratio (5Y)

0.59

Volume

418.1K

Weekly RSI

45.06

YTD price change

18.02%

YTD total return

18.02%

Metric	Value
Float	36.2M
Float percentage	57.83%
Shares change (QoQ)	1.74%
Shares change (YoY)	5.61%
Shares held by insiders	14.08%
Shares held by institutions	68.14%
Shares outstanding	62.6M
Short % of float	18.38%
Short % of shares	10.63%
Short ratio	8.7 days

Metric

Value

Float

36.2M

Float percentage

57.83%

Shares change (QoQ)

1.74%

Shares change (YoY)

5.61%

Shares held by insiders

14.08%

Shares held by institutions

68.14%

Shares outstanding

62.6M

Short % of float

18.38%

Short % of shares

10.63%

Short ratio

8.7 days

Design Therapeutics, Inc. (DSGN)

Price

Financial snapshot

Fair-value bridge

Latest news · DSGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DSGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on DSGN

Frequently asked questions